来自细胞的IL-17D通过控制单细胞招募来抑制过敏性喘
Lei Yuan1, Jinling Huang1, Jianhui Chen1
1Institute for Immunology and School of Basic Medicines, Tsinghua University , Beijing, China.
The Journal of experimental medicine
|August 5, 2025
概括
气道中的状细胞产生IL-17D,作为抗喘的免疫制动剂. 这种分子防止有害单细胞的招募,为肺部疾病治疗提供了一个新的目标.
科学领域:
- 肺免疫学 肺免疫学
- 皮质细胞生物学 皮质细胞生物学
- 过敏性炎症是一种过敏性炎症.
背景情况:
- 呼吸道上皮维持肺部平衡;调节障碍与喘等肺部疾病有关.
- 纤维化细胞对于清除呼吸道上皮质中的吸入颗粒和病原体至关重要.
研究的目的:
- 研究状细胞和IL-17D (IL-17D) 在过敏性肺炎和喘中的作用.
- 阐明IL-17D调节肺部免疫细胞透的机制.
主要方法:
- 用喘的小鼠模型来研究过敏性炎症.
- 在状细胞中对IL-17D的表达分析.
- 研究了IL-17D与CD93在单细胞上的相互作用.
- 在古典单细胞上评估化学因受体表达 (例如,CCR6).
主要成果:
- 状细胞构成性地表达IL-17D,这限制了喘模型中的过敏炎症.
- IL-17D与CD93结合,防止单细胞流入和致病性膜巨细胞的形成.
- Il17d或Cd93缺陷通过CCR6上调增强了单细胞招募和2型炎症.
结论:
- 纤维化细胞和IL-17D在肺免疫反应和喘中起着意想不到的保护作用.
- IL-17D/CD93通路代表了管理过敏呼吸道疾病的潜在治疗标.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
461
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
461
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Antiasthma Drugs: Leukotriene Modifiers
475
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
475
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Asthma: Pathogenesis and Management
593
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
593
Drugs Used in Lower Respiratory Disorders: Overview
583
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
583


